Transcatheter or Surgical Treatment of Aortic-Valve Stenosis.
Stefan BlankenbergMoritz SeiffertReinhard VontheinHelmut BaumgartnerSabine BleizifferMichael A BorgerYeong-Hoon ChoiPeter ClemmensenJochen CremerMartin CzernyNina DiercksIngo EitelStephan EnsmingerDerk FrankNorbert FreyAndreas HagendorffChristian HaglChristian HammUtz KappertMatthias KarckWon-Keun KimInke R KönigMarkus KraneUlf LandmesserAxel LinkeLars S MaierSteffen MassbergFranz-Josef NeumannHermann ReichenspurnerTanja K RudolphChristof SchmidHolger ThieleRaphael TwerenboldThomas WaltherDirk WestermannErion XhepaAndreas ZieglerVolkmar Falknull nullPublished in: The New England journal of medicine (2024)
Among patients with severe aortic stenosis at low or intermediate surgical risk, TAVI was noninferior to SAVR with respect to death from any cause or stroke at 1 year. (Funded by the German Center for Cardiovascular Research and the German Heart Foundation; DEDICATE-DZHK6 ClinicalTrials.gov number, NCT03112980.).